Evidence map›Paper›PMID 40660888›Full record

ArticleMedical physics2025

Early generation dynamic and static proton arc treatment planning algorithms assessment in oropharyngeal cancer patients.

Bas Adriaan De Jong, Lewei Zhao, Peilin Liu, Viktor Wase, Otte Marthin, Johan Sundström, Gang Liu, Rohan Deroniyagala, Xiaoqiang Li, Xiaoda Cong and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Proton therapy in Spain: SEOR-SPROMP multidisciplinary recommendations developed through a RAND/UCLA consensus process.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Bas Adriaan De JongDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Lewei ZhaoDepartment of Radiation Oncology, Stanford University, Palo Alto, California, USA.
Peilin LiuDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Viktor WaseResearch and Development, RaySearch Laboratories AB, Stockholm, Sweden.
Otte MarthinResearch and Development, RaySearch Laboratories AB, Stockholm, Sweden.
Johan SundströmResearch and Development, RaySearch Laboratories AB, Stockholm, Sweden.
Gang LiuDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Rohan DeroniyagalaDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Xiaoqiang LiDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Xiaoda CongDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Guillaume JanssensResearch and Development, Ion Beam Applications SA, Louvain-la-Neuve, Belgium.
Erik EngwallResearch and Development, RaySearch Laboratories AB, Stockholm, Sweden.
Erik W KorevaarDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Xuanfeng DingDepartment of Radiation Oncology, Corewell Health System, Rose Cancer Center, Royal Oak, Michigan, USA.
Johannes Albertus LangendijkDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Stefan BothDepartment of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Funding

Ministry of Economic Affairs and Climate Policy of the Netherlands
6 · The paper itself

Abstract

backgroundCompared with intensity modulated proton therapy (IMPT), proton arc treatment (PAT) employs an increased number of gantry angles, potentially reducing healthy tissues doses, especially for complex target geometries found in oropharyngeal cancer (OPC) treatment. PAT plans can be optimized with algorithms, based either on "static" gantry position or "dynamic" gantry movement during dose delivery. Recent results have shown target coverage may suffer more from inter-fraction patient anatomical- and setup changes In PAT than IMPT. PURPOSE: We assessed if PAT plans generated with one static and two dynamic PAT planning algorithms can improve expected plan toxicity, delivery time, and inter-fraction robustness compared to clinical volumetric modulated arc therapy (VMAT) and IMPT plans for OPC patients.

methodsSix OPC patients were included that qualified for proton therapy based on model-based selection, with IMPT plans superior to the VMAT plans in terms of toxicities. Static PAT plans were produced using an energy layer filtration (ELF) algorithm, and dynamic PAT plans were produced with two different methods: (1) Spot scanning Proton Arc (SPArc), and (2) Early Layer and Spot Assignment (ELSA). Two sets of PAT plans with about 360 or 240 energy layers and an additional ELF plan employing anterior oblique range shifted fields were produced. All proton plans were robustly optimized. Expected plan toxicity was determined using normal tissue complication probability (NTCP) models for dysphagia and xerostomia. A delivery time model was calibrated using experimental machine log-files and gantry dynamics from an IBA Proteus PLUS system (IBA Ltd, Belgium). Inter-fraction robustness was evaluated on a fraction-wise (on weekly repeated CT) and course-wise (accumulated over all weekly repeated CTs) basis.

resultsAll PAT strategies showed significantly (p-values < 0.05) reduced NTCPs for dysphagia and xerostomia grade ≥ 2 compared to IMPT and VMAT. Relative to VMAT, NTCP for xerostomia reduced by on average 4.0% in IMPT plans, 9.8% in ELF-, 9.6% in SPArc-, and 8.7% in ELSA PAT plans with 360 energy layers, and NTCP for dysphagia reduced by on average 9.6% in IMPT plans, 13.1% in ELF, 12.9% in SPArc, and 12.3% in ELSA PAT plans. Average clinical IMPT delivery time was 11.4 ± 2.1 min, while dynamic PAT delivery time was on average 7.6 ± 0.5 min for ELSA and 8.2 ± 0.5 min for SPArc plans with 360 energy layers and auto beam sequencing delivery for 360 energy layer 30 beam angle ELF plans was 9.9 ± 1.0 min. Reduction of energy layers to 240 resulted in limited NTCP increase, globally < 1%, and reduced delivery time by up to 3 min, where changes in delivery time and NTCP were largest in ELF plans. Fraction-wise target coverage was worse in the PAT plans compared to IMPT; however the course-wise coverage showed to be less impacted by inter-fraction changes. The addition of anterior oblique fields with range shifters markedly improved fraction- and course-wise target coverage for the ELF plans.

conclusionsThe tested static and dynamic PAT planning strategies showed similar significant reductions in NTCP compared to IMPT and VMAT. Estimated PAT delivery times were shorter compared to times for current delivery procedures of clinical IMPT plans. Dynamic PAT delivery is faster than static PAT. Fraction-wise robustness suffered more than course-wise robustness due to anatomical changes found in repeated CTs. Range shifters can be employed to improve PAT plan robustness.

Indexed as

AlgorithmsOropharyngeal NeoplasmsProton TherapyRadiotherapy Planning, Computer-AssistedHumansOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-Modulateddelivery timedynamic and Static PATnormal tissue complication probability (NTCP)oropharyngeal cancerproton treatmentrobustness

Identifiers

PMID40660888
PMCPMC12260774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.